These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
621 related articles for article (PubMed ID: 25348731)
1. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731 [TBL] [Abstract][Full Text] [Related]
2. Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery. Niccoli-Asabella A; Altini C; De Luca R; Fanelli M; Rubini D; Caliandro C; Montemurro S; Rubini G Biomed Res Int; 2014; 2014():952843. PubMed ID: 24877151 [TBL] [Abstract][Full Text] [Related]
3. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study. Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012 [TBL] [Abstract][Full Text] [Related]
4. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer. Sun W; Xu J; Hu W; Zhang Z; Shen W Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167 [TBL] [Abstract][Full Text] [Related]
5. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039 [TBL] [Abstract][Full Text] [Related]
6. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Maffione AM; Ferretti A; Grassetto G; Bellan E; Capirci C; Chondrogiannis S; Gava M; Marzola MC; Rampin L; Bondesan C; Colletti PM; Rubello D Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):853-64. PubMed ID: 23417501 [TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of serial Fernando S; Lin M; Pham TT; Chong S; Ip E; Wong K; Chua W; Ng W; Lin P; Lim S Br J Radiol; 2020 Jan; 93(1105):20190455. PubMed ID: 31617737 [TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI and Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566 [TBL] [Abstract][Full Text] [Related]
9. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038 [TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Lovinfosse P; Polus M; Van Daele D; Martinive P; Daenen F; Hatt M; Visvikis D; Koopmansch B; Lambert F; Coimbra C; Seidel L; Albert A; Delvenne P; Hustinx R Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):365-375. PubMed ID: 29046927 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation. Niccoli Asabella A; Simone M; Ballini A; Altini C; Ferrari C; Lavelli V; De Luca R; Inchingolo F; Rubini G Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8227-8236. PubMed ID: 30556862 [TBL] [Abstract][Full Text] [Related]
12. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer. Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822 [TBL] [Abstract][Full Text] [Related]
13. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation. Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901 [TBL] [Abstract][Full Text] [Related]
14. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275 [TBL] [Abstract][Full Text] [Related]
15. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology. Koç M; Kaya GÇ; Demir Y; Sürücü E; Sarioğlu S; Obuz F; Öztop İ; Görken İB; Sökmen S Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176 [TBL] [Abstract][Full Text] [Related]
16. Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Lee SJ; Kim JG; Lee SW; Chae YS; Kang BW; Lee YJ; Park JS; Choi GS Cancer Chemother Pharmacol; 2013 May; 71(5):1201-7. PubMed ID: 23420438 [TBL] [Abstract][Full Text] [Related]
17. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Ippolito D; Monguzzi L; Guerra L; Deponti E; Gardani G; Messa C; Sironi S Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580 [TBL] [Abstract][Full Text] [Related]
18. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Capirci C; Rubello D; Pasini F; Galeotti F; Bianchini E; Del Favero G; Panzavolta R; Crepaldi G; Rampin L; Facci E; Gava M; Banti E; Marano G Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1461-9. PubMed ID: 19419820 [TBL] [Abstract][Full Text] [Related]
19. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial. Guido A; Cuicchi D; Castellucci P; Cellini F; Di Fabio F; Llimpe FLR; Strigari L; Buwenge M; Cilla S; Deodato F; Macchia G; Galietta E; Golfieri R; Ardizzoni A; Zagari RM; Fanti S; Poggioli G; Fuccio L; Morganti AG Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):572-580. PubMed ID: 36127416 [TBL] [Abstract][Full Text] [Related]
20. Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer. Stiekema J; Vermeulen D; Vegt E; Voncken FE; Aleman BM; Sanders J; Boot H; van Sandick JW Clin Nucl Med; 2014 Oct; 39(10):862-7. PubMed ID: 25140549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]